| US 7,491,798 B2 | ||
| Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins | ||
| Michael R. Boyd, Mobile, Ala. (US); Heidi R. Bokesch, Frederick, Md. (US); Barry R. O'Keefe, Frederick, Md. (US); and Tawnya C. McKee, Gaithersburg, Md. (US) | ||
| Assigned to The United States of America as represented by the Department of Health and Human Services, Washington, D.C. (US) | ||
| Appl. No. 10/513,961 PCT Filed May 15, 2003, PCT No. PCT/US03/15991 § 371(c)(1), (2), (4) Date Dec. 20, 2004, PCT Pub. No. WO03/097814, PCT Pub. Date Nov. 27, 2003. |
||
| Claims priority of provisional application 60/381322, filed on May 16, 2002. | ||
| Prior Publication US 2005/0084496 A1, Apr. 21, 2005 | ||
| Int. Cl. C07K 14/195 (2006.01); C07H 21/00 (2006.01); A61K 38/00 (2006.01); C12N 5/00 (2006.01); C12N 1/00 (2006.01); C12N 1/20 (2006.01); C12N 1/14 (2006.01); C12N 15/00 (2006.01) | ||
| U.S. Cl. 530—350 [514/2; 435/325; 435/243; 435/252.1; 435/254.2; 435/320.1; 536/23.1; 536/23.7] | 46 Claims |
| 1. An isolated or purified antiviral protein comprising the amino acid sequence of SEQ ID NO: 1. |